Patterns of Lymph Node Metastases in Apparent Stage I Low-Grade Epithelial Ovarian Cancer: A Multicenter Study
Lucas Minig, Christina Fotopoulou(Ovarian Cancer Action), José Miguel Cárdenas‐Rebollo(Universidad San Pablo CEU), Ignacio Zapardiel(Hospital Universitario La Paz), Marco Petrillo(University of Sassari), Florian Heitz(Kliniken Essen-Mitte), Giovanni Scambia(Agostino Gemelli University Polyclinic), Jamie N. Bakkum‐Gamez(Mayo Clinic in Arizona), Eleftheria Kalogera(Mayo Clinic), Andreas du Bois(Kliniken Essen-Mitte), Vanna Zanagnolo(European Institute of Oncology), Sean C. Dowdy(Mayo Clinic), Kristina Lindemann(Norwegian Cancer Society), David Cibula(Charles University), Philipp Harter(Kliniken Essen-Mitte), Anna Germanová(Charles University), Cristina Zorrero(Fundación Instituto Valenciano de Oncología)
Cited by 54
Related Papers
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.4k
ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
|Annals of Oncology|2019|1.2k
Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2013|1.1k
<scp>FIGO</scp> staging of endometrial cancer: 2023
|International Journal of Gynecology & Obstetrics|2023|926